tiprankstipranks
Calliditas Therapeutics (CALT)
NASDAQ:CALT

Calliditas Therapeutics (CALT) Cash flow

112 Followers

Calliditas Therapeutics Cash Flow

CALT's free cash flow for Q4 2022 was kr―. For the 2022 fiscal year, CALT's free cash flow was decreased by kr170.38M and operating cash flow was kr―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
kr -541.38Mkr -311.35Mkr -461.59Mkr -309.18Mkr -71.01Mkr -128.19M
Investing Cash Flow
kr -3.68Mkr -5.14Mkr -24.34Mkr -172.61Mkr -18.07Mkr 0.00
Financing Cash Flow
kr 293.35Mkr 575.99Mkr 435.16Mkr 768.56Mkr 198.84Mkr 716.57M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
kr 2.41Bkr 1.58Bkr 1.40Bkr 996.30Mkr 753.54Mkr 646.17M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
--kr 324.00Mkr 891.39Mkr 210.32Mkr 768.65M
Issuance Of Debt
kr 236.46Mkr 480.87Mkr 179.09Mkr 0.00-kr 0.00
Repayment Of Debt
kr -6.75Mkr -10.88Mkr -20.43Mkr -3.97Mkr -1.65Mkr -470.00K
Free Cash Flow
kr -541.38Mkr -313.87Mkr -484.24Mkr -309.18Mkr -87.19Mkr -128.19M
Domestic Sales
------
Foreign Sales
------
Currency in SEK

Calliditas Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis